NCT01808521View on ClinicalTrials.gov

A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Purpura, Thrombotic ThrombocytopenicTTP
Interventions
DRUG

N-Acetylcysteine

IV administration of N-Acetylcysteine at 150mg/kg over 60 min first, then if well tolerated, 150mb/kg over 17 hours

Trial Locations (1)

98104

Puget Sound Blood Center, Seattle

All Listed Sponsors
collaborator

University of Washington

OTHER

lead

Bloodworks

OTHER

NCT01808521 - A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura | Biotech Hunter | Biotech Hunter